|
1
|
Bainey KR and Armstrong PW: Clinical
perspectives on reperfusion injury in acute myocardial infarction.
Am Heart J. 167:637–645. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Maxwell SR and Lip GY: Reperfusion injury:
a review of the pathophysiology, clinical manifestations and
therapeutic options. Int J Cardiol. 58:95–117. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yellon DM and Hausenloy DJ: Myocardial
reperfusion injury. N Engl J Med. 357:1121–1135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Buja LM: Myocardial ischemia and
reperfusion injury. Cardiovasc Pathol. 14:170–175. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Olivetti G, Quaini F, Sala R, Lagrasta C,
Corradi D, Bonacina E, Gambert SR, Cigola E and Anversa P: Acute
myocardial infarction in humans is associated with activation of
programmed myocyte cell death in the surviving portion of the
heart. J Mol Cell Cardiol. 28:2005–2016. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao ZQ, Nakamura M, Wang NP, Wilcox JN,
Shearer S, Ronson RS, Guyton RA and Vinten-Johansen J: Reperfusion
induces myocardial apoptotic cell death. Cardiovasc Res.
45:651–660. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Hori M and Nishida K: Oxidative stress and
left ventricular remodelling after myocardial infarction.
Cardiovasc Res. 81:457–464. 2009. View Article : Google Scholar
|
|
8
|
Wagner H: Synergy research: approaching a
new generation of phytopharmaceuticals. Fitoterapia. 82:34–37.
2011. View Article : Google Scholar
|
|
9
|
Combination Pharmacotherapy and Public
Health Research Working Group: Combination pharmacotherapy for
cardiovascular disease. Ann Intern Med. 143:593–599. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang L, Zhou GB, Liu P, Song JH, Liang Y,
Yan XJ, Xu F, Wang BS, Mao JH, Shen ZX, et al: Dissection of
mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as
an effective treatment for promyelocytic leukemia. Proc Natl Acad
Sci USA. 105:4826–4831. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li SJ, Tang YP, Shen J, Li JP, Guo JM and
Duan JA: Research of Chinese medicine pairs (VIII) - Salviae
Miltiorrhizae Radix et Rhizoma-Carthami flos. Zhongguo Zhong Yao Za
Zhi. 38:4227–4231. 2013.In Chinese.
|
|
12
|
Guan Y, Yin Y, Zhu YR, Guo C, Wei G, Duan
JL, Wang YH, Zhou D, Quan W, Weng Y, et al: Dissection of
mechanisms of a chinese medicinal formula: Danhong injection
therapy for myocardial ischemia/reperfusion injury in vivo and in
vitro. Evid Based Complement Alternat Med. 2013:9723702013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou D, Zhu YR, Guan Y, Quan W, Guo C,
Weng Y, Cui J, Chen L, Ding Y, Xi M and Wen A: Development of
chemical fingerprint and metabolic fingerprint of Danhong injection
by HPLC-UV and HPLC-MS. Asian J Chem. 25:6285–6292. 2013.
|
|
14
|
Duan JL, Wang JW, Guan Y, Yin Y, Wei G,
Cui J, Zhou D, Zhu YR, Quan W, Xi MM and Wen AD: Safflor yellow A
protects neonatal rat cardiomyocytes against anoxia/reoxygenation
injury in vitro. Acta Pharmacol Sin. 34:487–495. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yin Y, Guan Y, Duan J, Wei G, Zhu Y, Quan
W, Guo C, Zhou D, Wang Y, Xi M and Wen A: Cardioprotective effect
of Danshensu against myocardial ischemia/reperfusion injury and
inhibits apoptosis of H9c2 cardiomyocytes via Akt and ERK1/2
phosphorylation. Eur J Pharmacol. 699:219–226. 2013. View Article : Google Scholar
|
|
16
|
Zhou MX, Fu JH, Zhang Q and Wang JQ: The
effect of hydroxy safflower yellow A on inflammatory reaction in
myocardium of the rats after acute myocardial infarction. Afr J
Pharm Pharmacol. 7:643–649. 2013. View Article : Google Scholar
|
|
17
|
Cui G, Shan L, Hung M, Lei S, Choi I,
Zhang Z, Yu P, Hoi P, Wang Y and Lee SM: A novel Danshensu
derivative confers cardioprotection via PI3K/Akt and Nrf2 pathways.
Int J Cardiol. 168:1349–1359. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu SX, Zhang Y, Wang YF, Li XC, Xiang MX,
Bian C and Chen P: Upregulation of heme oxygenase-1 expression by
hydroxysafflor yellow A conferring protection from
anoxia/reoxygenation-induced apoptosis in H9c2 cardiomyocytes. Int
J Cardiol. 160:95–101. 2012. View Article : Google Scholar
|
|
19
|
Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera
JS, Halkos ME, Kerendi F, Guyton RA and Vinten-Johansen J:
Postconditioning attenuates myocardial ischemia-reperfusion injury
by inhibiting events in the early minutes of reperfusion.
Cardiovasc Res. 62:74–85. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sachdeva J, Dai W, Gerczuk PZ and Kloner
RA: Combined remote perconditioning and postconditioning failed to
attenuate infarct size and contractile dysfunction in a rat model
of coronary artery occlusion. J Cardiovasc Pharmacol Ther.
19:567–573. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao X, Wang T, Liu Y, Irwin MG, Ou JS,
Liao XL, Gao X, Xu Y, Ng KF, Vanhoutte PM and Xia Z:
N-acetylcysteine and allopurinol confer synergy in attenuating
myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in
diabetic rats. PLoS One. 8:e689492013. View Article : Google Scholar
|
|
22
|
Tsai CY, Wang CC, Lai TY, Tsu HN, Wang CH,
Liang HY and Kuo WW: Antioxidant effects of diallyl trisulfide on
high glucose-induced apoptosis are mediated by the
PI3K/Akt-dependent activation of Nrf2 in cardiomyocytes. Int J
Cardiol. 168:1286–1297. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chou TC: Drug combination studies and
their synergy quantification using the Chou-Talalay method. Cancer
Res. 70:440–446. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Won MH, Kang TC, Jeon GS, Lee JC, Kim DY,
Choi EM, Lee KH, Choi CD, Chung MH and Cho SS: Immunohistochemical
detection of oxidative DNA damage induced by ischemia-reperfusion
insults in gerbil hippocampus in vivo. Brain Res. 836:70–78. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Panteghini M, Cuccia C, Bonetti G,
Giubbini R, Pagani F and Bonini E: Single-point cardiac troponin T
at coronary care unit discharge after myocardial infarction
correlates with infarct size and ejection fraction. Clin Chem.
48:1432–1436. 2002.PubMed/NCBI
|
|
26
|
Turer AT, Mahaffey KW, Gallup D, Weaver
WD, Christenson RH, Every NR and Ohman EM: Enzyme estimates of
infarct size correlate with functional and clinical outcomes in the
setting of ST-segment elevation myocardial infarction. Curr Control
Trials Cardiovasc Med. 6:122005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Christenson RH, Vollmer RT, Ohman EM, Peck
S, Thompson TD, Duh SH, Ellis SG, Newby LK and Topol EJ: Relation
of temporal creatine kinase-MB release and outcome after
thrombolytic therapy for acute myocardial infarction. Am J Cardiol.
85:543–547. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thygesen K, Alpert JS, White HD, Jaffe AS,
Apple FS, Galvani M, Katus HA, Newby LK, Ravkilde J, Chaitman B, et
al: Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of
Myocardial Infarction: Universal definition of myocardial
infarction. Eur Heart J. 28:2525–2538. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Quan W, Yin Y, Xi M, Zhou D, Zhu Y, Guan
Y, Guo C, Wang Y, Duan J and Wen A: Antioxidant properties of
magnesium lithospermate B contribute to the cardioprotection
against myocardial ischemia/reperfusion injury in vivo and in
vitro. J Tradit Chin Med. 33:85–91. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Das DK, Engelman RM, Rousou JA, Breyer RH,
Otani H and Lemeshow S: Pathophysiology of superoxide radical as
potential mediator of reperfusion injury in pig heart. Basic Res
Cardiol. 81:155–166. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu J, Hecker JG and Chiamvimonvat N:
Antioxidant enzyme gene transfer for ischemic diseases. Adv Drug
Deliv Rev. 61:351–363. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wattanapitayakul SK and Bauer JA:
Oxidative pathways in cardiovascular disease: Roles, mechanisms,
and therapeutic implications. Pharmacol Ther. 89:187–206. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Günfer T, Yaşar E and Bünyamin K: Changes
in the levels of MDA and GSH in mice serum, liver and spleen after
aluminum administration. East J Med. 11:7–12. 2006.
|
|
34
|
Cordis GA, Maulik G, Bagchi D, Riedel W
and Das DK: Detection of oxidative DNA damage to ischemic
reperfused rat hearts by 8-hydroxydeoxyguanosine formation. J Mol
Cell Cardiol. 30:1939–1944. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zeng B, Chen H, Zhu C, Ren X, Lin G and
Cao F: Effects of combined mesenchymal stem cells and heme
oxygenase-1 therapy on cardiac performance. Eur J Cardiothorac
Surg. 34:850–856. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tang YL, Tang Y, Zhang YC, Qian K, Shen L
and Phillips MI: Improved graft mesenchymal stem cell survival in
ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J
Am Coll Cardiol. 46:1339–1350. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu CC, Hsu MC, Hsieh CW, Lin JB, Lai PH
and Wung BS: Upregulation of heme oxygenase-1 by
epigallocatechin-3-gallate via the phosphatidylinositol
3-kinase/Akt and ERK pathways. Life Sci. 78:2889–2897. 2006.
View Article : Google Scholar
|
|
38
|
Maines MD: The heme oxygenase system: a
regulator of second messenger gases. Annu Rev Pharmacol Toxicol.
37:517–554. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kutty RK, Kutty G, Rodriguez IR, Chader GJ
and Wiggert B: Chromosomal localization of the human heme oxygenase
genes: Heme oxygenase-1 (HMOX1) maps to chromosome 22q12 and heme
oxygenase-2 (HMOX2) maps to chromosome 16p13.3. Genomics.
20:513–516. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Scarabelli TM, Knight R, Stephanou A,
Townsend P, Chen-Scarabelli C, Lawrence K, Gottlieb R, Latchman D
and Narula J: Clinical implications of apoptosis in ischemic
myocardium. Curr Probl Cardiol. 31:181–264. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Saelens X, Festjens N, Vande Walle L, van
Gurp M, van Loo G and Vandenabeele P: Toxic proteins released from
mitochondria in cell death. Oncogene. 23:2861–2874. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Murphy KM, Streips UN and Lock RB: Bax
membrane insertion during Fas(CD95)-induced apoptosis precedes
cytochrome c release and is inhibited by Bcl-2. Oncogene.
18:5991–5999. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Salvesen GS: Caspases and apoptosis.
Essays Biochem. 38:9–19. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim KC, Kang KA, Zhang R, Piao MJ, Kim GY,
Kang MY, Lee SJ, Lee NH, Surh YJ and Hyun JW: Upregulation of
Nrf2-mediated heme oxygenase-1 expression by eckol, a phlorotannin
compound, through activation of Erk and PI3K/Akt. Int J Biochem
Cell Biol. 42:297–305. 2010. View Article : Google Scholar
|
|
45
|
Minelli A, Conte C, Grottelli S, Bellezza
I, Emiliani C and Bolaños JP: Cyclo(His-Pro) upregulates heme
oxygenase 1 via activation of Nrf2-ARE signalling. J Neurochem.
111:956–966. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lee IS, Lim J, Gal J, Kang JC, Kim HJ,
Kang BY and Choi HJ: Anti-inflammatory activity of xanthohumol
involves heme oxygenase-1 induction via NRF2-ARE signaling in
microglial BV2 cells. Neurochem Int. 58:153–160. 2011. View Article : Google Scholar
|
|
47
|
Ungvari Z, Bagi Z, Feher A, Recchia FA,
Sonntag WE, Pearson K, de Cabo R and Csiszar A: Resveratrol confers
endothelial protection via activation of the antioxidant
transcription factor Nrf2. Am J Physiol Heart Circ Physiol.
299:H18–H24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Mann GE, Niehueser-Saran J, Watson A, Gao
L, Ishii T, de Winter P and Siow RC: Nrf2/ARE regulated antioxidant
gene expression in endothelial and smooth muscle cells in oxidative
stress: implications for atherosclerosis and preeclampsia. Sheng Li
Xue Bao. 59:117–127. 2007.PubMed/NCBI
|
|
49
|
Lee S, Park Y, Zuidema MY, Hannink M and
Zhang C: Effects of interventions on oxidative stress and
inflammation of cardiovascular diseases. World J Cardiol. 3:18–24.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Imming P, Sinning C and Meyer A: Drugs,
their targets and the nature and number of drug targets. Nat Rev
Drug Discov. 5:821–834. 2006. View Article : Google Scholar : PubMed/NCBI
|
